Skip to main content
Clinical Trials/NCT04455256
NCT04455256
Completed
Not Applicable

Endoplasmic Reticulum Stress in Recurrent Pregnancy Loss

Kanuni Sultan Suleyman Training and Research Hospital1 site in 1 country90 target enrollmentMarch 20, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Recurrent Pregnancy Loss
Sponsor
Kanuni Sultan Suleyman Training and Research Hospital
Enrollment
90
Locations
1
Primary Endpoint
Show the effect of endoplasmic reticulum stress on recurrent pregnancy loss
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

To evaluate endoplasmic reticulum stress in women with recurrent pregnancy loss and those who had healthy births in the same age group. The level of the unfolded protein X box binding protein 1 (XBP-1) is measured. It is aimed to show the effect of endoplasmic reticulum stress on recurrent pregnancy loss.

Registry
clinicaltrials.gov
Start Date
March 20, 2020
End Date
July 7, 2020
Last Updated
5 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Pınar Yalcin bahat

Principal Investigator

Kanuni Sultan Suleyman Training and Research Hospital

Eligibility Criteria

Inclusion Criteria

  • with three or more miscarriages before 20 th week of gestation
  • had no chronic or acute inflammatory disease
  • used no steroids, anti-inflammatory, or antioxidant medications

Exclusion Criteria

  • had inflammatory diseases
  • had systemic disease
  • Anatomical abnormalities, infectious, endocrine, or genetic etiologies

Outcomes

Primary Outcomes

Show the effect of endoplasmic reticulum stress on recurrent pregnancy loss

Time Frame: 3 months

Serum value (pg / mL) of x box binding protein (XBP-1), which is one of the unfolded proteins indicating endoplasmic reticulum stress, is measured.

Study Sites (1)

Loading locations...

Similar Trials